Expands Options for Patients with Potential for. Reduced Reconstitution Time and Infusion Volume. SEATTLE, June 25, 2019 (GLOBE NEWSWIRE) -- Aptevo ...
Wednesday, 26 June 2019
Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients - GlobeNewswire
Aptevo Therapeutics Launches New 3000 IU IXINITY Assay Offering Enhanced User Experience and Improved Convenience for Hemophilia B Patients GlobeNewswire
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment